Phillip Engel
Collected: 2026-04-09
Reported: 2026-04-09
Lab: LabCorp · Fasting: No
Ferritin (ng/mL)
HDL Cholesterol (mg/dL)
Hemoglobin (g/dL)
ApoB (mg/dL)
Total Cholesterol / LDL / Triglycerides
Estradiol Sensitive (pg/mL)
Creatinine (mg/dL) & eGFR
Testosterone — Total (ng/dL)
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| WBC | 5.5 | 4.1 (04/2025) | 3.4-10.8 | Normal |
| RBC | 5.51 | 5.18 (04/2025) | 4.14-5.80 | Normal |
| Hemoglobin | 13.8 | 14.6 (04/2025) | 13.0-17.7 | Normal |
| Hematocrit | 44.8% | 45.1% (04/2025) | 37.5-51.0 | Normal |
| MCV | 81 | 87 (04/2025) | 79-97 | Normal |
| MCH | 25 | 28.2 (04/2025) | 26.6-33.0 | Low |
| MCHC | 30.8 | 32.4 (04/2025) | 31.5-35.7 | Low |
| RDW | 16.1% | 13.4% (04/2025) | 11.6-15.4 | High |
| Platelets | 228 | 194 (04/2025) | 150-450 | Normal |
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| Glucose | 83 | 74 (08/2025) | 70-99 | Normal |
| BUN | 21 | 23 (08/2025) | 6-24 | Normal |
| Creatinine | 1.42 | 1.04 (08/2025) | 0.76-1.27 | Creatine |
| eGFR | 57 | 83 (08/2025) | >59 | Creatine |
| Sodium | 137 | 139 (08/2025) | 134-144 | Normal |
| Potassium | 4.7 | 4.3 (08/2025) | 3.5-5.2 | Normal |
| Chloride | 101 | 101 (08/2025) | 96-106 | Normal |
| CO2 | 24 | 22 (08/2025) | 20-29 | Normal |
| Calcium | 9 | 9.2 (08/2025) | 8.7-10.2 | Normal |
| Protein, Total | 6.7 | 6.7 (08/2025) | 6.0-8.5 | Normal |
| Albumin | 4.5 | 4.6 (08/2025) | 3.8-4.9 | Normal |
| Globulin | 2.2 | 2.1 (08/2025) | 1.5-4.5 | Normal |
| Bilirubin, Total | 0.4 | 0.3 (08/2025) | 0.0-1.2 | Normal |
| Alk Phosphatase | 54 | 53 (08/2025) | 47-123 | Normal |
| AST (SGOT) | 28 | 24 (08/2025) | 0-40 | Normal |
| ALT (SGPT) | 27 | 29 (08/2025) | 0-44 | Normal |
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| Total Cholesterol | 170 | 180 (04/2025) | 100-199 | Normal |
| Triglycerides | 91 | 62 (04/2025) | 0-149 | Normal |
| HDL Cholesterol | 38 | 38 (04/2025) | >39 | Low |
| VLDL | 15 | 15 (07/2024) | 5-40 | Normal |
| LDL Calculated | 117 | 123 (07/2024) | 0-99 | High |
| LDL/HDL Ratio | 3.1 | — | 0.0-3.6 | Normal |
| Apolipoprotein B | 92 | 102 (06/2024) | <90 | Borderline* |
| Lipoprotein(a) | 37.6 | 38.5 (06/2024) | <75.0 | Normal |
| hs-CRP | 0.62 | 0.25 (06/2024) | 0.00-3.00 | Low Risk |
Lipid Context Note
ApoB and LDL values reflect only ~2 weeks off Pravastatin. True unmedicated baseline will be higher. Recheck lipids + ApoB in 6-8 weeks after restarting statin therapy. With documented coronary artery disease (cath Aug 2025), target ApoB is <80 mg/dL, ideally <70.
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| Testosterone, Total | 1165 | 448 (08/2025) | 264-916 | TRT Expected |
| Free Testosterone | 32.7 | 8.8 (08/2025) | 7.2-24.0 | TRT Expected |
| Estradiol, Sensitive | 30 | 17.9 (08/2025) | 8.0-35.0 | Optimal |
| TSH | 1.98 | 1.6 (04/2025) | 0.450-4.500 | Normal |
| Free T3 | 3 | 2.8 (04/2025) | 2.0-4.4 | Normal |
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| Hemoglobin A1c | 5.4% | 5% (06/2024) | 4.8-5.6 | Optimal |
| Fasting Insulin | 4.9 | — | 2.6-24.9 | Excellent |
| Glucose | 83 | 74 (08/2025) | 70-99 | Normal |
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| GGT | 30 | — | 0-65 | Normal |
| AST (SGOT) | 28 | 24 (08/2025) | 0-40 | Normal |
| ALT (SGPT) | 27 | 29 (08/2025) | 0-44 | Normal |
| Ferritin | 12 | 22 (06/2024) | 30-400 | Critical Low |
| Vitamin D, 25-OH | 59.7 | 51.9 (06/2024) | 30.0-100.0 | Optimal |
| Test | Result | Previous | Reference | Status |
|---|---|---|---|---|
| PSA Total | 0.9 | 0.9 (04/2025) | 0.0-4.0 | Normal |
- 1. Start Iron Supplementation — Immediately Ferrex 150 (polysaccharide-iron complex), 1 capsule every other day on empty stomach with vitamin C. Take 2 hours away from berberine, calcium, magnesium, coffee. Switch multivitamin to version with iron. Recheck ferritin in 8-12 weeks.
- 2. Restart Statin Therapy — This Week Contact prescribing physician. Resume Pravastatin. Discuss adding Ezetimibe to reach ApoB target <80 (ideally <70) given documented coronary artery disease. Recheck lipid panel + ApoB 6-8 weeks after restarting.
- 3. Fecal Immunochemical Test (FIT) — Within 1-2 Weeks Rule out occult GI blood loss as cause of declining ferritin. Order through Taylor at Marek Health (LabCorp) or purchase OTC. Daily aspirin use increases GI microbleed risk. If positive, GI referral warranted.
- 4. Lipid + ApoB Recheck — 6-8 Weeks After resuming statin, retest Lipid Panel + ApoB through Taylor at Marek. ~$40 estimated. Goal: confirm ApoB <80 on treatment.
- 5. Ferritin Recheck — 8-12 Weeks Confirm iron supplementation is working. Target: ferritin >50. If no improvement, investigate absorption issues or occult blood loss further.
- 6. Maintain Current Protocol DIM 200mg + Calcium D-Glucarate 500mg → estradiol well controlled at 30.0. TRT microdosing protocol stable. D3+K2 supplementation achieving target. Berberine + milk thistle → GGT/liver enzymes clean. No changes needed.
Interpretation Context
Creatinine / eGFR: Flagged values (1.42 / 57) are artifacts of 10g daily creatine monohydrate supplementation, not true kidney dysfunction. BUN normal at 21, BUN/Creatinine ratio normal at 15. A Cystatin C test would provide creatine-independent kidney assessment if verification desired.
Testosterone / Free T: Flagged high values expected on exogenous TRT protocol (daily microdosing ~30mg cypionate/enanthate). HPTA fully suppressed after 15+ years. No diurnal variation. Levels reflect steady-state, not a peak or trough.
Previous Testosterone (448 ng/dL, 08/2025): That draw likely occurred during a protocol adjustment or missed doses — current 1165 reflects the active daily microdosing protocol.
Iron Depletion Pattern: MCH low (25.0), MCHC low (30.8), RDW high (16.1), MCV declining (87→81), hemoglobin trending down (17.9→13.8 over 2 years), ferritin critically low (12). Classic early iron deficiency anemia developing. Hemoglobin still in range but trajectory is concerning. History of regular blood donations (stopped mid-2025) plus daily aspirin and supplement stack competing with iron absorption are likely contributors.